Edition:
India

Penumbra Inc (PEN.N)

PEN.N on New York Stock Exchange

158.25USD
18 May 2018
Change (% chg)

$2.90 (+1.87%)
Prev Close
$155.35
Open
$155.80
Day's High
$159.15
Day's Low
$155.80
Volume
45,682
Avg. Vol
59,856
52-wk High
$159.15
52-wk Low
$77.75

Chart for

About

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address... (more)

Overall

Beta: --
Market Cap(Mil.): $3,181.32
Shares Outstanding(Mil.): 33.77
Dividend: --
Yield (%): --

Financials

BRIEF-Penumbra, Inc. Reports Qtrly Earnings Per Share $0.15

* PENUMBRA, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-Penumbra Inc Sees FY 2018 Revenue $400 Mln To $405 Mln

* PENUMBRA, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

28 Feb 2018

BRIEF-Penumbra Announces Formation of Joint Venture, MVI Health

* PENUMBRA ANNOUNCES THE FORMATION OF JOINT VENTURE, MVI HEALTH

04 Jan 2018

Competitors

  Price Chg
Terumo Corp (4543.T) ¥6,500 +40.00
Johnson & Johnson (JNJ.N) $124.24 +0.39
Medtronic PLC (MDT.N) $84.64 -0.47
Stryker Corporation (SYK.N) $172.81 +1.55
Boston Scientific Corporation (BSX.N) $30.45 +0.13

Earnings vs. Estimates